article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Ultimately, they concluded that the available data on pain and other outcomes was unreliable, with a high risk of bias. On postoperative days 0, 1, 2, 7, 14, and 42, researchers with Thomas Jefferson University in Philadelphia collected data on patient pain, sleep, and opioid use. Let us know References: 1. Lefebvre, .;

Topical 179
article thumbnail

Could CBN really help you sleep? Consumer study data suggest yes.

The Cannigma

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Back to our study.

Sleep 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Study: Adult-Use Legalization Associated with Decline in Youth Treatment Admissions

NORML

The enactment of adult-use cannabis legalization laws is not associated with an increase in marijuana-related youth drug treatment admissions, according to data published in the journal Drug and Alcohol Dependence. A pair of researchers from Temple University assessed annual drug treatments admissions among youth for the years 2008 to 2017.

Treatment 295
article thumbnail

Report: Marijuana Legalization Not Associated with Adverse ‘Spillover’ Effects in Neighboring States

NORML

The study , entitled “Measuring the Criminal Justice System Impacts of Marijuana Legalization and Decriminalization Using State Data,” assessed the impact of adult-use regulation schemes on criminal justice resources in both legalization states and neighboring non-legalization states.

article thumbnail

Medicinal Genomics Secures Funding for a Better Cannabis Reference

Medicinal Genomics

Medicinal Genomics recently secured funding from the DASH network to create a better cannabis reference genome for controversially patented TypeII plants. Why do we need a better reference? A reference genome builds the standards by which fingerprints are created to provide biological barcodes for products in the industry.

article thumbnail

Canada: J&J’s Janssen Denied Data Protection Rights For Ketamine Analog Spravato In Canada, Court Rules ‘Not An Innovative Drug’

Cannabis Law Report

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98
article thumbnail

Australia Cannabis Q&A

Canna Law Blog

Data Privacy 29. What data privacy obligations do cannabis businesses have? Given the sensitive nature of medicinal cannabis information, businesses must comply with the Privacy Act 1988, including: Secure storage of patient data. Valid consent for data collection and use.